In this episode of SciBud, we dive into the groundbreaking research on appendiceal pseudomyxoma peritonei (PMP), a rare but impactful condition affecting patient outcomes. Host Rowan guides us through an innovative study that employs an interpretable machine learning model to noninvasively predict the pathological grade of PMP using advanced imaging techniques and clinical data. With insights from 158 patients, the research highlights the importance of accurate preoperative grading, revealing that patients with low-grade PMP have significantly better prognoses than those with high-grade tumors. By employing a combined model that incorporates both clinical markers, like the serum tumor marker CA-199, and sophisticated imaging data, the researchers achieved impressive accuracy rates. Plus, with the use of SHAP for interpreting model predictions, this study offers a glimpse into the future of individualized treatment planning, while reminding us of the necessary steps toward open-access data for reproducibility. Join us for an engaging exploration of how AI is reshaping the landscape of medical diagnostics and enhancing patient care! Link to episode page with article citation: www.scibud.media/podcast/season/2025/episode/103

Ver todos los episodios